Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 13 h ago

ABEONA THERAPEUTICS INC.: Rubric Capital Management LP discloses a stake of more than 5% (Schedule 13G)

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 16 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Rubric Capital Management LP disclosed a stake exceeding 5% in Abeona Therapeutics Inc. via a Schedule 13G filing with the SEC (accession 0001104659-26-128285). The exact share count and percentage were not specified in the filing headline. The disclosure signals a new or increased position by the activist-oriented investor in the gene therapy developer. Investors will watch for further filings or correspondence indicating whether Rubric intends to push for strategic or governance changes.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

Abeona Therapeutics Inc., Rubric Capital Management LP